Some hindrances susceptible to perturb the Bioprinting industry

Steadily, one can observe that, Bioprinting technology has huge market potential for healthcare segment particularly in organ fabrication.

According to Research and Markets, growth of the market is driven by widening demand-supply gap in organ transplants, application in drug toxicity testing and rising demand for orthopedic implants.

Many analysts believe that, certain factors such as regulatory hurdles, lack of skilled professionals, high costs and limited choice of biomaterials are hindering growth of the industry.

As major industry players operating in the global 3D Bioprinting market, we have Organovo Holdings, Inc., CELLINK AB, EnvisionTEC GmbH, BioBots, Inc. and Cyfuse Biomedical K.K., among others.